Xu B - Search Results

1

Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable-polymer coronary stent - five-year results of the TARGET All Comers randomised clinical trial.

Lansky AJ, Xu B, Baumbach A, Kelbæk H, van Royen N, Zheng M, Knaapen P, Slagboom T, Johnson TW, Vlachojannis GJ, Arkenbout KE, Holmvang L, Janssens L, Brugaletta S, Naber CK, Schmitz T, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina CM, Buszman PE, Thiele H, Schächinger V, Wijns W. Lansky AJ, et al. Among authors: xu b. EuroIntervention. 2023 Dec 4;19(10):e844-e855. doi: 10.4244/EIJ-D-23-00409. EuroIntervention. 2023. PMID: 37860860 Free PMC article. Clinical Trial.

2

Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry.

Gao RL, Xu B, Lu SZ, Chen JL, Han YL, Chen JZ, Gai LY, Ge JB, Wang WM, Du ZM, Huo Y, Wang LF, Gao W, Chen JY, He B, Jia GL, Yang ZJ, Cao KJ, Li WM, Shen WF, Wan Z, Huang DJ, Zhu GY; CCSR Investigators. Gao RL, et al. Among authors: xu b. Int J Cardiol. 2008 Apr 25;125(3):339-46. doi: 10.1016/j.ijcard.2007.02.031. Epub 2007 Apr 16. Int J Cardiol. 2008. PMID: 17434617

3

Stent thrombosis following 2 drug-eluting stent implantations for coronary bifurcation lesion: a single-center analysis.

Gao Z, Xu B, Yang Y, Chen J, Qiao S, Li JJ, Qin X, Wu Y, Yao M, Yuan J, Chen J, Liu H, Dai J, Gao RL. Gao Z, et al. Among authors: xu b. J Interv Cardiol. 2010 Aug;23(4):346-51. doi: 10.1111/j.1540-8183.2010.00565.x. J Interv Cardiol. 2010. PMID: 20718906 Free article.

4

First report of a novel abluminal groove filled biodegradable polymer rapamycin-eluting stent in de novo coronary artery disease: results of the first in man FIREHAWK trial.

Qian J, Xu B, Lansky AJ, Yang YJ, Qiao SB, Wu YJ, Chen J, Hu FH, Yang WX, Mintz GS, Leon MB, Gao RL. Qian J, et al. Among authors: xu b. Chin Med J (Engl). 2012 Mar;125(6):970-6. Chin Med J (Engl). 2012. PMID: 22613516 Clinical Trial.

5

Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial.

Xu B, Dou K, Yang Y, Lv S, Wang L, Wang H, Li Z, Wang L, Chen Y, Huo Y, Li W, Kirtane AJ, Gao R. Xu B, et al. EuroIntervention. 2012 Nov 22;8(7):796-802. doi: 10.4244/EIJV8I7A122. EuroIntervention. 2012. PMID: 23171800 Free article. Clinical Trial.

6

Five-year clinical follow-up of unprotected left main bifurcation lesion stenting: one-stent versus two-stent techniques versus double-kissing crush technique.

Chen SL, Zhang Y, Xu B, Ye F, Zhang J, Tian N, Liu Z, Qian X, Ding S, Li F, Zhang A, Liu Y, Lin S. Chen SL, et al. Among authors: xu b. EuroIntervention. 2012 Nov 22;8(7):803-14. doi: 10.4244/EIJV8I7A123. EuroIntervention. 2012. PMID: 23171801 Free article.

7

A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study.

Han YL, Zhang L, Yang LX, Liu HL, Qu P, Li WM, Jiang TM, Li SM, Jing QM, Zhang QY, Xu B, Li Y, Gao RL. Han YL, et al. Among authors: xu b. EuroIntervention. 2012 Nov 22;8(7):815-22. doi: 10.4244/EIJV8I7A124. EuroIntervention. 2012. PMID: 23171802 Free article.

8

Outcomes of overlapping heterogeneous drug-eluting stents versus homogeneous drug-eluting stents for diffuse lesions in small coronary arteries.

Liu SW, Qiao SB, Xu B, Hu FH, Chen J, Yuan JQ, Wu YJ, Yang YJ, Chen JL, Gao RL. Liu SW, et al. Among authors: xu b. J Interv Cardiol. 2013 Jun;26(3):264-70. doi: 10.1111/j.1540-8183.2013.12023.x. Epub 2013 Mar 14. J Interv Cardiol. 2013. PMID: 23488819 Free article.

9

Efficacy and safety of FIREHAWK® abluminal groove filled biodegradable polymer sirolimus-eluting stents for the treatment of long coronary lesions: nine-month angiographic and one-year clinical results from TARGET I trial long cohort.

Xu B, Gao RL, Zhang RY, Wang HC, Li ZQ, Yang YJ, Ma CS, Han YL, Lansky AJ, Huo Y, Li W, Leon MB. Xu B, et al. Chin Med J (Engl). 2013 Mar;126(6):1026-32. Chin Med J (Engl). 2013. PMID: 23506573

10

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial.

Gao RL, Xu B, Lansky AJ, Yang YJ, Ma CS, Han YL, Chen SL, Li H, Zhang RY, Fu GS, Yuan ZY, Jiang H, Huo Y, Li W, Zhang YJ, Leon MB; TARGET I Investigators. Gao RL, et al. Among authors: xu b. EuroIntervention. 2013 May 20;9(1):75-83. doi: 10.4244/EIJV9I1A12. EuroIntervention. 2013. PMID: 23685298 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,895 results

Search Page

Filters